Non-Invasive Assessment of Pulmonary Vasculopathy

Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibili...

Descripción completa

Detalles Bibliográficos
Autores: Ponz, Ines, Nuche, Jorge, Sánchez Sánchez, Violeta, Sánchez González, Javier, Blázquez Bermejo, Zorba, Caravaca Pérez, Pedro, García Cosio Carmena, Maria Dolores, Juan Baguda, Javier S. De, Rodríguez Chaverri, Adriana Rodríguez, Sarnago Cebada, Fernando, Arribas Ynsaurriaga, Fernando, Ibañez, Borja, Delgado Jiménez, Juan Francisco
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/7057
Acceso en línea:https://hdl.handle.net/20.500.14352/7057
Access Level:acceso abierto
Palabra clave:Heart failure
Pulmonary hypertension
Cardiovascular magnetic resonance
Right heart catheterization
Cardiología
Neumología
3205.01 Cardiología
3205.08 Enfermedades Pulmonares
Descripción
Sumario:Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, for the prognostic evaluation of patients with chronic heart failure. The non-invaSive Assessment of Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess the feasibility and prognostic relevance of a non-invasive evaluation of the pulmonary artery vasculature in patients with heart failure and pulmonary hypertension. Patients will undergo a right heart catheterization, cardiac resonance imaging, and a pulmonary function test in order to identify structural and functional parameters allowing the identification of combined pre- and postcapillary pulmonary hypertension, and correlate these findings with the hemodynamic data.

Similares en LA Referencia